User profiles for Lise Estcourt
Lise EstcourtAssociate Professor University of Oxford Verified email at nhsbt.nhs.uk Cited by 14542 |
Hyperimmune immunoglobulin for people with COVID‐19
…, Z McQuilten, C So-Osman, LJ Estcourt… - Cochrane Database …, 2023 - cochranelibrary.com
Background Hyperimmune immunoglobulin (hIVIG) contains polyclonal antibodies, which
can be prepared from large amounts of pooled convalescent plasma or prepared from animal …
can be prepared from large amounts of pooled convalescent plasma or prepared from animal …
Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review
…, Z McQuilten, C So-Osman, LJ Estcourt… - Cochrane Database …, 2021 - cochranelibrary.com
Background Convalescent plasma and hyperimmune immunoglobulin may reduce mortality
in patients with viral respiratory diseases, and are being investigated as potential therapies …
in patients with viral respiratory diseases, and are being investigated as potential therapies …
Granulocyte transfusions for treating infections in people with neutropenia or neutrophil dysfunction
LJ Estcourt, SJ Stanworth, S Hopewell… - Cochrane Database …, 2016 - cochranelibrary.com
Background Despite modern antimicrobials and supportive therapy bacterial and fungal
infections are still major complications in people with prolonged disease‐related or treatment‐…
infections are still major complications in people with prolonged disease‐related or treatment‐…
Interleukin-6 receptor antagonists in critically ill patients with Covid-19–preliminary report
Background The efficacy of interleukin-6 receptor antagonists in critically ill patients with
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
coronavirus disease 2019 (Covid-19) is unclear. Methods We evaluated tocilizumab and …
Guidelines for the use of platelet transfusions
L Estcourt, J Birchall, S Allard, S Bassey… - British journal of …, 2016 - ora.ox.ac.uk
The demand for platelets in England was stable at around 220,000 adult therapeutic doses (ATD)
per year until 2007/8 at which point demand has increased year on year to 275,000 …
per year until 2007/8 at which point demand has increased year on year to 275,000 …
Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19: the REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
…, A Buzgau, AC Cheng, M de Jong, M Detry, L Estcourt… - Jama, 2020 - jamanetwork.com
… Dr Estcourt reported receiving grants from the NIHR during the conduct of the study. Dr
Fitzgerald reported receiving grants for PREPARE Network from the European Commission, …
Fitzgerald reported receiving grants for PREPARE Network from the European Commission, …
Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a meta-analysis
Importance Clinical trials assessing the efficacy of IL-6 antagonists in patients hospitalized
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
for COVID-19 have variously reported benefit, no effect, and harm. Objective To estimate the …
Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. …
treatment of COVID-19. However, meta-analysis data and recommendations are limited. …
[HTML][HTML] A no-prophylaxis platelet-transfusion strategy for hematologic cancers
SJ Stanworth, LJ Estcourt, G Powter… - … England Journal of …, 2013 - Mass Medical Soc
Background The effectiveness of platelet transfusions to prevent bleeding in patients with
hematologic cancers remains unclear. This trial assessed whether a policy of not giving …
hematologic cancers remains unclear. This trial assessed whether a policy of not giving …
SARS‐CoV‐2‐neutralising monoclonal antibodies for treatment of COVID‐19
Background Monoclonal antibodies (mAbs) are laboratory‐produced molecules derived
from the B cells of an infected host. They are being investigated as a potential therapy for …
from the B cells of an infected host. They are being investigated as a potential therapy for …